FreeGulliver LLC’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$367K Buy
3,893
+1
+0% +$95 0.17% 60
2026
Q2
$329K Buy
3,892
+4
+0.1% +$323 0.12% 83
2026
Q1
$275K Sell
3,888
-460
-11% -$34.4K 0.12% 79
2025
Q4
$343K Buy
4,348
+13
+0.3% +$1.03K 0.13% 63
2025
Q3
$357K Buy
4,335
+462
+12% +$36.4K 0.16% 63
2025
Q2
$311K Sell
3,873
-6
-0.2% -$463 0.14% 62
2025
Q1
$311K Buy
3,879
+23
+0.6% +$1.91K 0.15% 63
2024
Q4
$316K Sell
3,856
-93
-2% -$7.74K 0.15% 59
2024
Q3
$326K Buy
3,949
+93
+2% +$6.95K 0.19% 52
2024
Q2
$271K Hold
3,856
– – 0.19% 57
2024
Q1
$286K Hold
3,856
– – 0.25% 44
2023
Q4
$255K Buy
+3,856
New +$241K 0.34% 32

Other funds holding MET

FreeGulliver LLC's MET Position: Q3 2026 in Review

FreeGulliver LLC increased its MetLife (MET) stake by 0.03% in Q3 2026, buying an estimated $95 and bringing the position to 3,893 shares worth $367K. The position accounts for 0.17% of the portfolio, ranked #60.

FreeGulliver LLC first reported a position in MET in Q4 2023 and has held it in 12 quarters since. 956 funds tracked by Wall St. Rank hold MET as of Q3 2026.

  • FreeGulliver LLC held 3,893 shares of MetLife worth $367K as of Q3 2026.
  • FreeGulliver LLC bought 1 MetLife share in Q3 2026, an estimated $95.
  • MetLife made up 0.17% of FreeGulliver LLC's portfolio in Q3 2026, its #60 holding.
  • FreeGulliver LLC first reported a position in MetLife in Q4 2023 and has held it in 12 quarters since.
  • 956 funds tracked by Wall St. Rank held MetLife as of Q3 2026.

Based on FreeGulliver LLC's 13F filing for Q3 2026, filed 10 Nov 2026.